Accuracy Coverage Pricing Contact
Zoetis Inc

Zoetis Inc - Class A Shares (ZTS)

Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. As of December 31, 2016, the Company had approximately 300 product lines, including products for both livestock and companion animals across each of its product categories. As of December 31, 2016, the Company marketed its products to veterinarians and livestock producers located in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America.

The Company's livestock products primarily help prevent or treat diseases. The Company's anti-infectives products prevent, kill or slow the growth of bacteria, fungi or protozoa. Its vaccines help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response. Its parasiticides products prevent or eliminate external and internal parasites such as fleas, ticks and worms. Its medicated feed additives are added to animal feed that provide medicines to livestock. Its other pharmaceutical products include pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. It offers other product categories, such as nutritionals and agribusiness, as well as products and services in various areas, including biodevices, diagnostics and genetics. The Company's portfolio includes diagnostics products such as the Witness line of immunodiagnostic kits. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Cydectin, Dectomax, Aureomycin, Lasalocid line, Lincomycin line, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, Vanguard line, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

The Company competes with Boehringer Ingelheim GmbH, Merck & Co., Inc., Eli Lilly and Company, and Bayer AG.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 0.0c 0%
2013 20.0c 100%
2014 28.8c 44.0%
2015 33.2c 15.3%
2016 38.0c 14.5%
2017 42.0c 10.5%
2018 50.4c 20.0%
2019 Login required
2020 Login required
2021 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
29 Apr 2013 06 Jun 2013 2013 Interim Quarterly Paid 6.5c
30 Jul 2013 02 Sep 2013 2013 Interim Quarterly Paid 7c
30 Oct 2013 02 Dec 2013 2013 Final Quarterly Paid 6.5c
28 Jan 2014 04 Mar 2014 2014 Interim Quarterly Paid 7.2c
24 Apr 2014 02 Jun 2014 2014 Interim Quarterly Paid 7.2c
18 Aug 2014 02 Sep 2014 2014 Interim Quarterly Paid 7.2c
03 Nov 2014 02 Dec 2014 2014 Final Quarterly Paid 7.2c
20 Jan 2015 03 Mar 2015 2015 Interim Quarterly Paid 8.3c
07 Apr 2015 02 Jun 2015 2015 Interim Quarterly Paid 8.3c
11 Aug 2015 01 Sep 2015 2015 Interim Quarterly Paid 8.3c
03 Nov 2015 01 Dec 2015 2015 Final Quarterly Paid 8.3c
19 Jan 2016 01 Mar 2016 2016 Interim Quarterly Paid 9.5c
05 Apr 2016 01 Jun 2016 2016 Interim Quarterly Paid 9.5c
28 Jun 2016 30 Aug 2016 2016 Interim Quarterly Paid 9.5c
01 Nov 2016 01 Dec 2016 2016 Final Quarterly Paid 9.5c
18 Jan 2017 01 Mar 2017 2017 Interim Quarterly Paid 10.5c
04 Apr 2017 01 Jun 2017 2017 Interim Quarterly Paid 10.5c
13 Jun 2017 01 Sep 2017 2017 Interim Quarterly Paid 10.5c
08 Nov 2017 01 Dec 2017 2017 Final Quarterly Paid 10.5c
18 Jan 2018 01 Mar 2018 2018 Interim Quarterly Paid 12.6c
19 Apr 2018 01 Jun 2018 2018 Interim Quarterly Paid 12.6c
19 Jul 2018 04 Sep 2018 2018 Interim Quarterly Paid 12.6c
19 Nov 2018 03 Dec 2018 2018 Final Quarterly Paid 12.6c
17 Jan 2019 01 Mar 2019 2019 Interim Quarterly Paid 16.4c
17 Apr 2019 03 Jun 2019 2019 Interim Quarterly Paid 16.4c
18 Jul 2019 03 Sep 2019 2019 Interim Quarterly Paid 16.4c
21 Oct 2019 02 Dec 2019 2019 Final Quarterly Declared 16.4c
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Final Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Final Quarterly Forecast Login

Zoetis Inc - Class A Shares optimized dividend - 12 month history

Optimized dividend graph demo

Zoetis Inc - Class A Shares share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial